Bracco Diagnostics, Inc

Quick facts

Marketed products

• Arm 2 - Magnevist
• CardioGen-82
• Iodixanol 320 · Diagnostic Imaging
  Iodixanol is a non-ionic, iso-osmolar contrast medium that provides radiographic visualization of blood vessels and organs during diagnostic imaging procedures.
• Iopamidol 370
• Iopamidol 370 mgI/dL · Diagnostic Imaging
  Iopamidol is a non-ionic iodinated contrast medium that increases radiodensity in blood vessels and tissues to enhance visualization during radiographic imaging procedures.
• Iopamidol 370 mgI/mL · Diagnostic Imaging
  Iopamidol is a non-ionic iodinated contrast medium that increases radiodensity in blood vessels and tissues to enhance visualization during radiographic imaging procedures.
• Iopamidol injection 76% · Diagnostic Imaging
  Iopamidol is a non-ionic iodinated contrast agent that increases radiodensity in blood vessels and tissues to enhance visualization during radiographic imaging procedures.
• Isovue · Other
• Isovue 250 · Diagnostic Imaging
  Isovue 250 is an iodinated contrast medium that increases radiodensity in blood vessels and tissues to enhance visualization during X-ray and CT imaging procedures.
• Magnevist · Other
• MULTIHANCE: · Other
• MultiHance 0.05 mmol/kg · Diagnostic Imaging
  MultiHance is a gadolinium-based contrast agent that enhances magnetic resonance imaging (MRI) by shortening the T1 relaxation time of water protons in tissues.
• MultiHance 0.1 mmol/kg · Hematology
• Non ionic contrast media comparator · Diagnostic Imaging
  Non-ionic contrast media enhance the visibility of blood vessels and organs during radiographic imaging by increasing radiodensity without causing significant osmotic effects.
• ProHance
• VISIPAQUE 270 · Diagnostic Imaging
  Visipaque 270 is a non-ionic, iso-osmolar contrast medium that provides radiographic visualization of blood vessels and organs during diagnostic imaging procedures.

Phase 3 pipeline

• SonoVue-enhanced ultrasound · Diagnostic Imaging
  SonoVue is a microbubble contrast agent that enhances ultrasound imaging by reflecting ultrasound waves, improving visualization of blood flow and tissue perfusion.

Phase 2 pipeline

• iodinated contrast agent

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Bracco Diagnostics, Inc portfolio CI brief
• Bracco Diagnostics, Inc pipeline updates RSS